Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Luciano J. Costa, MD PhD, Simona Iacobelli, Marcelo C. Pasquini, MD, Riddhi Modi, PhD, Luisa Giaccone, Joan Bladé, MD PhD, Stefan Schonland, Andrea Evangelista, Jose A. Perez-Simon, MD PhD, Parameswaran Hari, MBBS, MD, Elizabeth E. Brown, PhD MPH, Sergio A Giralt, MD, Francesca Patriarca, Edward A. Stadtmauer, MD FACP, Laura Rosinol, MD PhD, Amrita Y. Krishnan, MD, Goesta Gahrton, MD PhD, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 259.

https://doi.org/10.1182/blood-2019-121367

Published: 2019

Journal Articles

Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT

Blood (2018) 132 (Supplement 1): 3464.

https://doi.org/10.1182/blood-2018-99-114402

Published: 2018

Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplant In Patients With Multiple Myeloma: A Comparison Of Planned Autologous-Reduced Intensity Allogeneic Stem Cell Transplant (Auto-Allo) and Reduced Intensity Allogeneic Stem Cell Transplant (RIC) As Upfront Transplant In Patients With Multiple Myeloma, An EBMT Analysis

Firoozeh Sahebi, MD, Simona Iacobelli, Ph. D., Anja Van Biezen, Liisa Volin, MD, Peter Dreger, Mauricette Michallet, MD, PhD, Per T. Ljungman, MD, PhD, Goesta Gahrton, MD, PhD, Curly TCM Morris, MD, Stefan Schonland, Theo de Witte, MD, Laurent Garderet, MD, Nicolaus Kroeger, MD, Anja Henseler, Nicolaas PM Schaap, MD, PhD, D Caballero, Xavier Poire, MD, Jakob Passweg, Rose-Marie Hamljadi

Blood (2013) 122 (21): 920.

https://doi.org/10.1182/blood.V122.21.920.920

Published: 2013

Journal Articles

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Nicolaus Kröger, MD, Avichai Shimoni, Georgia Schilling, Rainer Schwerdtfeger, MD, Martin Bornhäuser, Arnon Nagler, Axel R. Zander, Marion Heinzelmann, Ronald Brand, Goesta Gahrton, MD, PhD, Currly Morris, Dietger Niederwieser, T. M. de Witte

Blood (2009) 114 (22): 2308.

https://doi.org/10.1182/blood.V114.22.2308.2308

Published: 2009

Journal Articles

The Prognostic Significance of 8p21 Deletion in Multiple Myeloma

Hareth Nahi, Tolga Sutlu, Evren Alici, Goesta Gahrton, MD, PhD

Blood (2008) 112 (11): 5153.

https://doi.org/10.1182/blood.V112.11.5153.5153

Published: 2008

Journal Articles

Impact of Chromosome 13 Deletion and Plasma Cell Load on Long-Term Survival of Patients with Multiple Myeloma Undergoing Autologous Transplantation

Esbjörn Paul, Tolga Sutlu, Evren Alici, Goesta Gahrton, MD, PhD, Hareth Nahi

Blood (2008) 112 (11): 5148.

https://doi.org/10.1182/blood.V112.11.5148.5148

Published: 2008

Journal Articles

Disruption of the Hexb/Enc-1 Antisense Gene and Identification of Elevated Enc-1 Expression in Patients with Hairy Cell Leukemia.

Mikael Lerner, Marianne Hammarsund, PhD, Olle Sangfelt, PhD, Chaoyong Zhu, PhD, Mats Merup, MD, PhD, Monika Jansson, Goesta Gahrton, MD, PhD, Hanneke Kluin-Nelemans, MD, PhD, Stefan Einhorn, MD, PhD, Dan Grander, MD, PhD, Martin Corcoran, PhD

Blood (2004) 104 (11): 1538.

https://doi.org/10.1182/blood.V104.11.1538.1538

Published: 2004

NARROW

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

The Prognostic Significance of 8p21 Deletion in Multiple Myeloma

Impact of Chromosome 13 Deletion and Plasma Cell Load on Long-Term Survival of Patients with Multiple Myeloma Undergoing Autologous Transplantation

Disruption of the Hexb/Enc-1 Antisense Gene and Identification of Elevated Enc-1 Expression in Patients with Hairy Cell Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

The Prognostic Significance of 8p21 Deletion in Multiple Myeloma

Impact of Chromosome 13 Deletion and Plasma Cell Load on Long-Term Survival of Patients with Multiple Myeloma Undergoing Autologous Transplantation

Disruption of the Hexb/Enc-1 Antisense Gene and Identification of Elevated Enc-1 Expression in Patients with Hairy Cell Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only